Table 2

Baseline characteristics of the patients according to completion of study

CharacteristicsComplete (n=8)Incomplete (n=7)Z-test statisticp Value
Age (years)56.5 (45–68)64 (53–66)−1.1020.296
Gender (male/female)6/22/50.132
Duration of therapy (months)25 (15–88)27 (12–180)−0.0810.960
Preimplant oral morphine dose (mg/day)60 (20–120)60 (40–240)−0.2410.869
Morphine dose (mg/day)3.065 (1.02–5.65)1.6 (0.62–5.5)−1.2730.232
Adjuvant intrathecal medication (yes/no)5/34/31.000
Bupivacaine dose (mg/day)2.5 (1.7–4.25)2.085 (1.86–2.12)−0.7350.556
Visual analogue scale44.5 (0–69)54 (23–64)−0.5220.632
Oswestry Disability Index53 (12–64)57.7 (42–72)−1.2220.244
Hospital Anxiety and Depression (HAD) scale
 HAD anxiety7 (2–16)8 (1–12)−0.1160.934
 HAD depression9 (2–15)7 (2–12)−0.8160.447
Coping Strategies Questionnaire
 Diverting attention12 (0–29)13 (0–31)−0.5010.649
 Reinterpreting pain sensation0 (0–19)3.5 (0–26)−0.4660.714
 Catastrophising22 (2–31)15 (1–27)−0.5750.608
 Ignoring pain sensations8 (0–21)8 (0–28)−0.2150.861
 Praying or hoping15 (2–30)18.5 (0–25)−0.3580.760
 Coping self-statements24 (13–30)19 (2–32)−0.3580.755
 Increasing activity level16 (3–30)13.5 (6–29)−0.1430.916
 Control over pain2 (1–5)3.5 (2–4)−1.1010.317
 Ability to decrease pain2 (1–4)3 (2–4)−1.0500.386
 Cognitive coping and suppression32 (12–70)32.5 (6–83)−0.0001.000
 Helplessness−5 (−14 to 11)0 (−36 to 10)−0.2150.868
 Diverting attention and praying/hoping27 (2–54)31.5 (0–56)−0.2870.809
  • Median (minimum–maximum); gender and adjuvant intrathecal medication were evaluated using Fisher's exact test; all other variables analysed using the Mann-Whitney U test (Exact sig. (2-tailed)); statistical significance represented at p<0.05.